Tower Research Capital LLC (TRC) - RXI PHARMACEUTICALS CORP NEW ownership

RXI PHARMACEUTICALS CORP NEW's ticker is RXIIXXXX and the CUSIP is 74979C501. A total of 19 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of RXI PHARMACEUTICALS CORP NEW
ValueSharesWeighting
Q3 2016$1,0003370.00%
Other shareholders

There were no reported owners of RXI PHARMACEUTICALS CORP NEW in Q3 2016.

NameSharesValueWeighting ↓
View complete list of RXI PHARMACEUTICALS CORP NEW shareholders